Factors predicting the efficacy of botulinum toxin-A treatment of the lower limb in children with cerebral palsy

Journal of Child Neurology

Volumn 20, Issue 8, 2005, Pages 661-666

  Fazzi, Elisa ^a   Maraucci, Ilaria ^a   Torrielli, Simona ^a   Motta, Francesco ^a   Lanzi, Giovanni ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A;

ADOLESCENT; ADULT; AGE; ARTICLE; BURNING SENSATION; CEREBRAL PALSY; CHILD; COGNITION; COGNITIVE DEFECT; DISABILITY; DISEASE SEVERITY; DRUG EFFECT; DRUG EFFICACY; FEMALE; FOLLOW UP; HEMIPLEGIA; HUMAN; INJECTION SITE REACTION; LEG; LEG MUSCLE; MAJOR CLINICAL STUDY; MALE; MOTOR CONTROL; MOTOR PERFORMANCE; PERIPHERAL VISION; PREDICTION; PRIORITY JOURNAL; RANGE OF MOTION; RATING SCALE; RISK FACTOR; SPASTICITY; TREATMENT OUTCOME; TREATMENT RESPONSE; VISUAL ACUITY;

ADOLESCENT; AGE FACTORS; BOTULINUM TOXIN TYPE A; CEREBRAL PALSY; CHILD; CHILD, PRESCHOOL; COGNITION; DISABLED PERSONS; FEMALE; HEMIPLEGIA; HUMANS; MALE; MOTOR SKILLS; MUSCLE SPASTICITY; NEUROMUSCULAR AGENTS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RANGE OF MOTION, ARTICULAR; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; VISUAL ACUITY; WALKING;

EID: 30944436047     PISSN: 08830738     EISSN: None     Source Type: Journal    
DOI: 10.1177/08830738050200080501     Document Type: Article

References (29)

1. Dolly JO, Black J, Williams RS, Melling J: Acceptors for botulinum toxin reside on the motor nerve terminal and mediate its internalisation. Nature 1984;307:457-460.
2. Koman LA, Mooney JF III, Goodman A: Management of valgus hindfoot deformity in pediatric cerebral palsy patients by medial displacement osteotomy. J Pediatr Orthop 1993;13:180-183.
3. Koman LA, Mooney JF III, Smith BP, et al: Management of cerebral palsy with botulinum-A toxin: Preliminary investigation. J Pediatr Orthop 1993;13:489-495.
4. Koman LA, Mooney JF III, Smith BP, et al: Management of spasticity in cerebral palsy with botulinum-A toxin: Report of a preliminary, randomized, double-blind trial. J Pediatr Orthop 1994;14:299-303.
5. Denislic M, Meh D: Botulinum toxin in the treatment of cerebral palsy. Neuropediatrics 1995;26:249-252.
6. Cosgrove AP, Corry IS, Graham HK: Botulinum toxin in the management of the lower limb in cerebral palsy. Dev Med Child Neurol 1994;36:386-396.
7. Boyd RN, Graham HK: Botulinum toxin A in the management of children with cerebral palsy: Indications and outcome. Eur J Neurol 1997;4(Suppl 2):15-22.
8. Corry IS, Cosgrove AP, Walsh EG, et al: Botulinum toxin A in the hemiplegic upper limb: A double blind trial. Dev Med Child Neurol 1997;39:185-193.
9. Calderon-Gonzalez R, Calderon-Sepulveda R, Rincon-Reyes M, et al: Botulinum toxin A in management of cerebral palsy. Pediatr Neurol 1994;10:284-288.
10. Zelnik N, Giladi N, Goikhman I, et al: The role of botulinum toxin in the treatment of lower limb spasticity in children with cerebral palsy - A pilot study. Isr J Med Sci 1997;33:129-133.
11. Sutherland DH, Kaufman KR, Wyatt MP, et al: Double-blind study of botulinum A toxin injections into the gastrocnemius muscle in patients with cerebral palsy. Gait Posture 1999;10:1-9.
12. Koman LA, Mooney JF III, Smith BP, et al: Botulinum toxin type A neuromuscular blockade in the treatment of lower extremity spasticity in cerebral palsy. A randomized, double-blind, placebo-controlled trial. Botox Study Group. J Pediatr Orthop 2000;20: 108-115.
13. Eames NW, Baker R, Hill N, et al: The effect of botulinum toxin A on gastrocnemius length: Magnitude and duration of response. Dev Med Child Neurol 1999;41:226-232.
14. Graham HK, Aoki KR, Autti-Ramo I, et al: Recommendations for the use of botulinum toxin type A in the management of cerebral palsy. Gait Posture 2000;11:67-79.
15. Bakheit AM, Severa S, Cosgrove A, et al: Safety profile and efficacy of botulinum toxin A (Dysport®) in children with muscle spasticity. Dev Med Child Neurol 2001;43:234-238.
16. Fattal-Valevski A, Giladi N, Domanievitz D, et al: Parameters for predicting favorable responses to botulinum toxin in children with cerebral palsy. J Child Neurol 2002;17:272-277.
17. Hagberg B, Hagberg G, Olow I: The changing panorama of cerebral palsy in Sweden 1954-1970. I. Analysis of the general changes. Acta Paediatr Scand 1975;64:187-192.
18. Palisano RJ, Rosenbaum PL, Walter SD, et al: Development and reliability of a system to classify gross motor function in children with cerebral palsy. Dev Med Child Neurol 1997;39:214-223.
19. Ashworth B: Preliminary trial of carisoprodal in multiple sclerosis. Practitioner 1964;192:540-542.
20. Bohannon RW, Smith MB: Inter-rater reliability of a modified Ashworth Scale of muscle spasticity. Phys Ther 1987;67:206-207.
21. Russell DJ, Rosenbaum PL, Cadman DT, et al: The Gross Motor Function Measure: A means to evaluate the effects of physical therapy. Dev Med Child Neurol 1989;31:341-352.
22. Boyd RN, Graham HK: Objective measurement of clinical findings in the use of botulinum toxin type A for the management of children with cerebral palsy. Eur J Neurol 1999;6(Suppl 4):23-25.
23. Tardieu G, Stentoub S, Delarue R: [Research on a technique for measurement of spasticity]. Rev Neurol (Paris) 1954;91:143-144.
24. McDowell BC, Hewitt V, Nurse A, et al: The variability of goniometric measurements in ambulatory children with spastic cerebral palsy. Gait Posture 2000;12:114-121.
25. Allington NJ, Leroy N, Doneux C: Ankle joint range of motion measurements in spastic cerebral palsy children: Intraobserver and interobserver reliability and reproducibility of goniometry and visual estimation. J Pediatr Orthop B 2002;11:236-239.
26. Lanzi G, Fazzi E, Uggetti C, et al: Cerebral visual impairment in periventricular leukomalacia. Neuropediatrics 1998;29:145-150.
27. Griffiths R: The Abilities of Babies. London, The Test Agency, 1986.
28. Wechsler Intelligence Scale for Children-Revised. New York, The Psychological Corporation, 1974.
29. Galli M, Crivellini M, Santambrogio GC, et al: Short-term effects of "botulinum toxin A" as treatment for children with cerebral palsy: Kinematic and kinetic aspects at the ankle joint. Funct Neurol 2001;16:317-323.